PATIENT-REPORTED BURDEN OF CORTICOSTEROID USE IN INFLAMMATORY BOWEL DISEASE IN THE UK: RESULTS FROM THE DETERMINANTS, INCIDENCE AND CONSEQUENCES OF CORTICOSTEROID EXCESS (DICE) IMPACT QUESTIONNAIRE

Eman Al Sulais  1     Gareth Parkes  2     Krisztina B. Gecse  3     Tricia Finney-Hayward  4     Christian Selinger  5     Tim Raine  1    
1 Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom
2 Royal London Hospital, London, United Kingdom
3 Amsterdam UMC, Amsterdam, Netherlands
4 AbbVie Ltd, Maidenhead, United Kingdom
5 Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Topic
IBD, Nurses

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing